Court of Appeal upholds UKIPO rejection of SPC for Parkinson’s treatment

The UK Court of Appeal has dismissed an appeal brought by Newron Pharmaceuticals concerning an SPC for a drug to treat Parkinson’s disease.
February 22, 2024
All about the disease